跳至主要内容
临床试验/ACTRN12622000847718
ACTRN12622000847718招募中未知

Verbal Behavior Analysis informed by Relational Frame Theory on a comorbid sample within the areas of depression, anxiety and Obsessive Compulsive Disorder - A mixed methods design with multiple baseline design with six clients and interpretative phenomenological analysis to test feasibility, acceptability and effectiveness.

Kompetenscentrum för psykoterapi, Centrum för psykitriforskning0 个研究点目标入组 6 人开始时间: 2022年6月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • (1) participant is at least 18 years of age and
  • (2) have a minimum of two comorbid psychiatric disorders within anxiety disorders, obsessive-compulsive disorder and depression.
  • (3) if regular pharmacological treatment for anxiety, obsessive-compulsive disorder, depression and eating disorder occurs, participation require stable doses for at least two months before the start of the measurements is allowed.
  • (4) participants must have undergone conventional treatment for one of their current
  • diagnoses previously.
  • (5) fluent in Swedish
  • (6) have access to internet and able to use smartphone or computer
  • (7) able to attend sessions on regular weekdays (9-5pm) 1-2 times a week

排除标准

  • (1) other ongoing psychological treatment,
  • (2) factors that appear that cause a new treatment to be considered inappropriate, eg., ongoing manic or psychotic episode, alcohol or substance abuse as well as other problems that suggest other treatments as first choice,
  • (3) increased suicide risk emerged from item 9 on Montgomery Åsberg Depression Rating Scale (MADRS-S; Svanborg & Åsberg, 1994; 4 points or more) and
  • (4) persons with a total score of over 34 points (severe depression) on MADRS-S.

研究者

发起方
Kompetenscentrum för psykoterapi, Centrum för psykitriforskning

相似试验

A process-based psychological treatment informed by... | 临床试验